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Background
While HAART allows for the reconstitution of immune
functions in most treated HIV patients, failure to
achieve a significant increase in circulating CD4+ T
cells despite undetectable viremia occurs.
Methods
A retrospective study was conducted to evaluate the
treatment outcome in a subgroup of 232 patients who
after 3.1 years of treatment had not achieved desirable
immune reconstitution despite a good virological
response to HAART.
Results
After a further 3.5±2.7 years of HAART, 41 (17.7%)
patients achieved immune reconstitution (681.4±172.7
CD4 cells/µL), while 191 (82.3%) patients did not (306.6
±109.16 cells/µL); the difference in the achieved CD4
counts between these subgroups was significant
(P<0.01). One patient experienced treatment failure. Ele-
ven patients died to the end of follow-up, of which ten
with a continuously dissociated response. Factors asso-
ciated with immune recovery included, usage of PIs and
of drugs from all three classes (OR 2.1, 95% CI 1.0-4.2,
P=0.037 and OR 5.1, 95% CI 1.4-18.7, P=0.013, respec-
tively), and a rise in CD4 count to over 200 cell/µL after
the first 3.1 years of treatment (OR 2.8, 95% CI 1.1-6.6,
P=0.019). Achievement of a rise in CD4 count to over
200 cell/µL after the first 3.1 years of treatment, and
usage of all three drug classes were independent predic-
tor of immune reconstitution in the following period.
Conclusions
If patients on HAART reach CD4 cell counts of above
200 cells/µL in the first three years, immune recovery is
possible after at least six years of treatment, particularly
if treated with drugs from all three classes.
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